Advertisement
TwistDx
TwistDx

The Scientist

» alternative splicing and disease/medicine

Most Recent

Contributors

April 1, 2012

Meet some of the people featured in the April 2012 issue of The Scientist.

0 Comments

image: Antibiotics in the Animals We Eat

Antibiotics in the Animals We Eat

By | April 1, 2012

Low-dose antibiotics in animal feed fuel drug-resistance in human infectious diseases.

0 Comments

image: Are Cancer Stem Cells Ready for Prime Time?

Are Cancer Stem Cells Ready for Prime Time?

By | April 1, 2012

A flood of new discoveries has refined our definition of cancer stem cells. Now it’s up to human clinical trials to test if they can make a difference in patients.

48 Comments

image: Deliberating Over Danger

Deliberating Over Danger

By | April 1, 2012

The creation of H5N1 bird flu strains that are transmissible between mammals has thrown the scientific community into a heated debate about whether such research should be allowed and how it should be regulated.

16 Comments

image: Speaking of Science

Speaking of Science

By | April 1, 2012

April 2012's selection of notable quotes

2 Comments

image: Failed Drugs Expose Preclinical Blunders

Failed Drugs Expose Preclinical Blunders

By | March 30, 2012

Once a promising cancer treatment, the failure of PARP inhibitors in the clinic may be due to flawed preclinical studies.

2 Comments

image: Courts Re-Examining Gene Patents

Courts Re-Examining Gene Patents

By | March 28, 2012

The US Supreme Court ordered patents held by Myriad Genetics to be reviewed further by the Federal Circuit Court.

2 Comments

image: Mouse Made For You

Mouse Made For You

By | March 23, 2012

Mice “avatars” grafted with patient tumor tissue help identify effective drug regimens.

4 Comments

image: Upheaval Over Children’s Health Study

Upheaval Over Children’s Health Study

By | March 21, 2012

A second advisor for the National Children’s Study resigns in response to changes in study design.

0 Comments

image: Prometheus Patents Overturned

Prometheus Patents Overturned

By | March 20, 2012

The US Supreme Court ruled that two dose calibration methods from biotech company Prometheus Laboratories cannot be patented.

12 Comments

Advertisement
RayBiotech
RayBiotech

Popular Now

  1. Opinion: Too Many Mitochondrial Genome Papers
  2. Antibiotics and the Gut Microbiome
  3. Sex Differences in Pain Pathway
  4. Anti-Vax Doctor Found Dead
    The Nutshell Anti-Vax Doctor Found Dead

    Police are calling the death of James Bradstreet, a physician who claimed vaccines cause autism and offered autism cures to patients, an apparent suicide.

Advertisement
Bina Technologies
Bina Technologies
Advertisement
The Scientist